| Financial Year |
March 31 2023 |
| Monetary Funds |
944,600,092.97 |
| Held-for-trading Financial Assets |
6,898,078.21 |
| Notes Receivable |
-- |
| Accounts Receivable |
976,405,349.22 |
| Advances to Suppliers |
264,055,672.30 |
| Other Receivables |
75,416,803.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,108,980,829.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
849,023,112.45 |
| Total Current Assets |
5,584,713,300.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
147,235,893.66 |
| Investment Properties |
140,531,900.00 |
| Fixed Assetes |
2,628,225,228.89 |
| Under-construction Projects |
974,726,235.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
300,662,221.51 |
| R&D expenses |
-- |
| Goodwill |
169,839,404.83 |
| Long-Term Deferred and Prepaid Expenses |
19,719,697.46 |
| Deferred Income Tax Assets |
154,103,334.64 |
| Other Non-Current Assets |
67,994,612.82 |
| Sub-Total of Non-Current Assets |
4,638,641,773.45 |
| Total Assets |
10,223,355,074.30 |
| Short-Term Loans |
184,977,022.17 |
| Trading Financial liabilities |
629,880.77 |
| Notes Payable |
370,300,000.00 |
| Accounts Payable |
1,604,012,680.90 |
| Accounts Received In Advance |
199,777.98 |
| Employee Compensation Payable |
122,352,425.46 |
| Taxes Payable |
122,281,982.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
258,406,823.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
295,614,213.08 |
| Sub-Total of Current Liabilities |
4,320,498,464.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
946,806.64 |
| Special Payable |
-- |
| Estimatied Liabilities |
14,384,402.33 |
| Deferred Income Tax Liabilities |
70,538,117.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
153,162,319.26 |
| Total Liabilities |
4,473,660,783.88 |
| Paid-In Capital(Or Share Stock) |
557,954,442.00 |
| Capital Surplus |
1,419,221,515.12 |
| Surplus Reserve |
256,491,520.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,508,556,980.33 |
| Minority Stockholder's Interest |
889,812,299.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,859,881,990.63 |
| Owner's Equity（Stockholder's Equity） |
5,749,694,290.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,223,355,074.30 |
